EUVIMEDОткрийте EUVIMED
Open access · CC BY-NC 4.0

Psychotropic medication use in early pregnancy: impacts on child socio‐emotional and behavioral development

Marion Lecorguillé iD, Cindy-Lee Dennis iD, Guillaume Elgbeili, Cindy Hénault Robert, Tim F Oberlander, Gillian E Hanley, Simone N Vigod, Kieran J O'Donnell, Tina C Montreuil iD

Journal of Child Psychology and Psychiatry · 2026-11-17

DOI: 10.1111/jcpp.70255 ↗

At a glance

Journal article in Journal of Child Psychology and Psychiatry, published online on 2026-11-17. Written by Marion Lecorguillé and 8 co-authors. Institution: Department of Educational and Counselling Psychology, Faculty of Education, McGill University, Montreal, QC, Canada. 75 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Canadian Transdisciplinary Training Program in Perinatal Research on Medications (CAMCCO-L, Chamandy Foundation, Canada First Research Excellence Fund Healthy Brains for Healthy Lives.

РезюмеSubjectsБиблиографски данниCiteRelated studies

Abstract (original language)

Background

Clinical symptoms of distress (anxiety or depression) affect around 10%–25% of women during the perinatal period, which, if left untreated, can adversely affect both maternal health and child development. Psychotropic medications are often first‐line treatments for maternal distress in pregnancy, but their effects on child socio‐emotional development remain underexplored. This study aims to compare socio‐emotional and behavioral development of children at 18 and 36 months according to early pregnancy exposure to treated or untreated maternal distress.

Methods

This project is based on the Montreal Antenatal Well‐Being Study, a prospective cohort study of 1,130 pregnant individuals from Quebec, Canada. Women self‐reported their medication use and were categorized as: (1) Untreated maternal distress, (2) Psychotropic medication use, (3) Control group (no maternal distress, no psychotropic medication). Analyses of covariance were used to examine the associations between exposure groups and indices of child socio‐emotional and behavioral development, assessed using the Early Childhood Behavior Questionnaire and the Child Behavior Checklist. To better account for baseline symptom severity and treatment indication, propensity score weighting was used to create comparable groups with balanced covariates such as socioeconomic status and health care access.

Results

Approximately 9.4% of women reported psychotropic medication use in early pregnancy. Analyses of covariance showed that maternal psychotropic medication use was associated with child inhibited temperament at 18 months and greater social withdrawal at 36 months. Propensity weighting revealed that these associations were largely driven by unmeasured confounding, showing no lasting associations with medication. In contrast, children born to mothers with untreated distress had poorer socio‐emotional development.

Conclusions

Our findings underscore the critical importance of appropriate statistical control of confounding in observational studies of maternal medication use and child outcomes. They also emphasize the impact of maternal distress on child development and the need for access to effective perinatal treatments.

Subjects

Author keywords

Early pregnancyanxietychild behaviordepressionpsychotropic medicationsocio‐emotional development

Authors and institutions

  • Department of Educational and Counselling Psychology, Faculty of Education, McGill University, Montreal, QC, Canada.
  • Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
  • Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, ON, Canada.
  • Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada.
  • Douglas Research Centre, Montreal, QC, Canada.
  • Division of Developmental Pediatrics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.

ORCID profiles: Marion Lecorguillé, Cindy-Lee Dennis, Tina C Montreuil

Funding

  • Canadian Transdisciplinary Training Program in Perinatal Research on Medications (CAMCCO-L
  • Chamandy Foundation
  • Canada First Research Excellence Fund Healthy Brains for Healthy Lives

Cite

APA

Lecorguillé, M., Dennis, C. L., Elgbeili, G., Robert, C. H., Oberlander, T. F., Hanley, G. E., Vigod, S. N., O'Donnell, K. J., & Montreuil, T. C. (2026). Psychotropic medication use in early pregnancy: impacts on child socio‐emotional and behavioral development. Journal of Child Psychology and Psychiatry. https://doi.org/10.1111/jcpp.70255

Vancouver

Lecorguillé M, Dennis CL, Elgbeili G, Robert CH, Oberlander TF, Hanley GE, et al. Psychotropic medication use in early pregnancy: impacts on child socio‐emotional and behavioral development. Journal of Child Psychology and Psychiatry. 2026. doi:10.1111/jcpp.70255

BibTeX
@article{Lecorguill2026,
  author = {Lecorguillé, Marion and Dennis, Cindy-Lee and Elgbeili, Guillaume and Robert, Cindy Hénault and Oberlander, Tim F and Hanley, Gillian E and Vigod, Simone N and O'Donnell, Kieran J and Montreuil, Tina C},
  title = {Psychotropic medication use in early pregnancy: impacts on child socio‐emotional and behavioral development},
  journal = {Journal of Child Psychology and Psychiatry},
  year = {2026},
  doi = {10.1111/jcpp.70255}
}
Start for free →